Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MCTS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RAB28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCLRE1C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NCBP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZCCHC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP3K2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HHEX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BBS7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXO9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF304 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NTAN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBMX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DAZAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRPF18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITPKB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on